All Posts By

Smartkarma Newswire

Intl Flavors & Fragrances (IFF) Earnings: 1Q Net Sales Align with Estimates Despite Mixed Segment Results

By | Earnings Alerts
  • International Flavors reported first-quarter net sales of $2.84 billion, aligning with expectations of $2.83 billion.
  • Health & Biosciences achieved net sales of $540 million, surpassing expectations of $530.4 million, marking a 1.7% increase year-over-year.
  • Scent segment net sales were $614 million, a decrease of 4.8% year-over-year but still slightly above the estimate of $610.9 million.
  • Pharma Solutions posted net sales of $266 million, significantly exceeding the estimate of $232 million, with a robust 17% year-over-year growth.
  • Adjusted earnings per share (EPS), excluding amortization, were $1.20, up from $1.13 year-over-year and above the expected $1.13.
  • The company maintains its 2025 full-year sales forecast between $10.6 billion and $10.9 billion.
  • Full-year adjusted operating EBITDA is projected at $2 billion to $2.15 billion.
  • Comparable currency neutral adjusted operating EBITDA is anticipated to grow 5% to 10% year-over-year.
  • CEO Erik Fyrwald highlighted disciplined execution and broad-based business growth as the drivers of solid first-quarter results.
  • The CEO also noted that growth and productivity initiatives have led to a significant increase in profitability.
  • The stock ratings comprised 15 buys, 4 holds, and 2 sells.

Intl Flavors & Fragrances on Smartkarma



Analyst coverage of International Flavors & Fragrances (IFF) on Smartkarma by Baptista Research is notably positive. In their report titled “Innovation & Expansion in Health & Biosciences Driving Our Bullishness,” Baptista Research highlights IFF’s strong financial results for the fourth quarter and full year 2024. With $11.5 billion in sales and a 6% growth in comparable currency-neutral sales, IFF is showing significant progress. The adjusted operating EBITDA also saw a substantial 16% increase, indicating a positive outlook.

Furthermore, Baptista Research‘s report on “Global Expansion” emphasizes IFF’s impressive performance in the third quarter of 2024. The company achieved a revenue growth surpassing $2.9 billion, a 9% increase on a comparable, currency-neutral basis. This growth was primarily driven by volume improvements in key segments such as Nourish, Health & Biosciences, Scent, and Pharma Solutions. Overall, the analyst sentiment leans bullish, reflecting confidence in IFF’s expansion and innovation strategies.



A look at Intl Flavors & Fragrances Smart Scores

FactorScoreMagnitude
Value4
Dividend3
Growth3
Resilience2
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

International Flavors & Fragrances Inc. is positioned for a promising long-term outlook based on a comprehensive analysis using Smartkarma Smart Scores. With strong scores in Value and Momentum, the company showcases robust potential for growth and profitability. Additionally, its moderate scores in Dividend and Growth indicate a stable and sustainable business model, further reinforcing confidence in its future performance. Although the Resilience score is comparatively lower, the overall outlook for Intl Flavors & Fragrances remains positive across key factors.

International Flavors & Fragrances Inc. specializes in creating and supplying flavors and fragrances for various industries, including food, beverage, personal care, and household products. With a focus on developing unique formulas through blending and mixing diverse ingredients, the company stands out for its innovative approach in the competitive market. Leveraging its solid foundation and impressive Smart Scores, Intl Flavors & Fragrances is poised to maintain a favorable position in the industry and drive value for its stakeholders in the long run.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Voya Financial (VOYA) Earnings: 1Q Adjusted Operating EPS Surpasses Estimates at $2.00

By | Earnings Alerts
  • Voya Financial‘s first quarter adjusted operating earnings per share (EPS) was $2.00.
  • This figure surpasses the previous year’s EPS of $1.77.
  • The earnings also exceeded analysts’ estimates of $1.40.
  • After-tax adjusted operating earnings for the period were reported at $195 million.
  • This considerably outperforms the estimate of $140.6 million.
  • Analyst ratings for Voya Financial include 7 buy, 5 hold, and 1 sell recommendations.

A look at Voya Financial Smart Scores

FactorScoreMagnitude
Value4
Dividend4
Growth2
Resilience3
Momentum3
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Voya Financial seems to be positioned well for the long term. With strong scores in Value and Dividend at 4, the company appears to offer sound investment potential and consistent dividend payouts. However, its Growth score of 2 indicates that there may be some challenges in expanding its business. The Resilience and Momentum scores at 3 each suggest a moderate level of stability and market performance. Overall, Voya Financial, Inc., a retirement, investment, and insurance company in the U.S., seems to have a solid foundation with room for growth.

Voya Financial‘s focus on asset accumulation, protection, and distribution products for both individual and institutional customers in the United States positions it well within the financial services industry. The company’s emphasis on long-term value and dividends reflects its commitment to providing stability and returns to its investors. While growth may be a slightly weaker aspect for Voya Financial, its resilience and momentum scores indicate a reasonable level of adaptability and market presence. Investors may find Voya Financial an attractive option for a balanced investment portfolio based on these Smartkarma Smart Scores.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Mosaic Co/The (MOS) Earnings: 1Q Adjusted EPS Surpasses Estimates with Strong EBITDA Performance

By | Earnings Alerts
  • Mosaic’s adjusted earnings per share (EPS) in the first quarter were $0.49, surpassing estimates of $0.45 but down from $0.65 year-on-year.
  • The company’s net sales were reported at $2.6 billion, a decrease of 3% from the previous year and slightly below the estimate of $2.63 billion.
  • Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) amounted to $544 million, a 5.6% decline year-on-year, but exceeded the estimate of $515.4 million.
  • Analysts’ recommendations for Mosaic include 10 buys, 9 holds, and 1 sell.

Mosaic Co/The on Smartkarma



Analyst coverage of Mosaic Co/The on Smartkarma reveals insights from Baptista Research. In a report titled “The Mosaic Company: An Insight Into The Phosphate and Potash Market Dynamics & Critical Growth Levers,” the analyst highlights a mixed performance in the fourth quarter of 2024. The company reported a net income of $169 million and an adjusted EBITDA of $594 million, driven by rising phosphate prices and strong stripping margins. Despite challenges in key segments, Mosaic Co/The demonstrated solid performance in potash.

Furthermore, Baptista Research‘s analysis in “The Mosaic Company: How Its Brazilian Market Expansion Driving Our β€˜Outperform’ Rating! – Major Drivers” focuses on the third quarter of 2024. Despite operational challenges like hurricanes in the U.S. and electrical issues at potash mines, The Mosaic Company achieved revenues of $2.8 billion. With a net income of $122 million and adjusted EBITDA of $448 million, the company’s strategic transitions and performance in the fertilizer industry are closely monitored by analysts.



A look at Mosaic Co/The Smart Scores

FactorScoreMagnitude
Value5
Dividend4
Growth2
Resilience3
Momentum5
OVERALL SMART SCORE3.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts at Smartkarma have given Mosaic Co/The a mix of scores that provide insight into its long-term outlook. With a top score of 5 in Value and Momentum, the company seems to be in a strong position in terms of its inherent worth and market performance. Its robust dividend score of 4 also indicates a potential for steady income for investors. However, Mosaic Co/The received a lower score of 2 for Growth, suggesting that there may be room for improvement in terms of expansion and development. Additionally, a score of 3 in Resilience indicates a moderate capability to withstand economic challenges.

Mosaic Co/The primarily focuses on producing and distributing crop nutrients for agricultural communities in North America and beyond, with its key products being concentrated phosphates and potash. Despite facing challenges in terms of growth and resilience, the company’s high scores in value and momentum highlight strengths in its market positioning and investment potential for the future.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Devon Energy (DVN) Earnings: 1Q Lease Operating Expenses Exceed Estimates Despite Strong Free Cash Flow

By | Earnings Alerts
  • Devon Corporation’s lease operating expenses for the first quarter were higher than expected, totaling $479 million.
  • This marks a 26% increase in lease operating expenses compared to the same period last year.
  • The company had initially estimated their operating expenses would be $454.1 million for the quarter.
  • Despite higher expenses, Devon reported a free cash flow of $1.01 billion, which is a 19% increase year-over-year.
  • The current analyst ratings for Devon include 22 buys, 11 holds, and 1 sell.

Devon Energy on Smartkarma

Analyst coverage of Devon Energy on Smartkarma reveals insights from Baptista Research. In the report “Devon Energy: Operational Efficiency In The Eagle Ford As A Strategic Growth Enabler!” by Baptista Research, Devon Energy‘s fourth-quarter 2024 performance is highlighted. The company showcased impressive operational performance, generating $3 billion in free cash flow. This financial strength facilitated a return of $2 billion to shareholders, aligning with Devon’s commitment to delivering shareholder value.

Furthermore, in another report by Baptista Research titled “Devon Energy: Expansion & Resource Optimization in the Williston Basin Driving Our Optimism! – Major Drivers,” Devon Energy‘s third quarter 2024 results are discussed. The report outlines both positive operational achievements, such as reaching an all-time quarterly high of 728,000 barrels of oil equivalent per day, and areas needing attention. The strong production numbers reflect a 12% year-over-year growth, leading to upward revisions to the company’s full-year production assumptions.


A look at Devon Energy Smart Scores

FactorScoreMagnitude
Value4
Dividend4
Growth3
Resilience4
Momentum4
OVERALL SMART SCORE3.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Devon Energy Corporation, an independent energy company focusing on oil and gas exploration and production, has received positive Smartkarma Smart Scores across various key factors. With strong scores in Value, Dividend, Resilience, and Momentum, Devon Energy demonstrates solid fundamentals and market momentum.

While the Growth score is slightly lower at 3, the overall outlook for Devon Energy appears optimistic. The company’s operations in oil, gas, and NGLs, along with marketing and midstream activities in North America, position it well for long-term success in the energy sector.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Jack Henry & Associates (JKHY) Earnings: FY EPS Forecast Raised, Surpasses Estimates with Strong Q3 Results

By | Earnings Alerts
  • Jack Henry increased its full-year earnings per share (EPS) forecast to between $6.00 and $6.09, up from the previous guidance of $5.78 to $5.87.
  • The updated full-year EPS estimate surpasses analysts’ expectations, which were at $5.80.
  • For adjusted revenue, Jack Henry foresees an outcome of $2.33 billion to $2.34 billion, compared to the prior projection of $2.35 billion to $2.38 billion.
  • Expected overall revenue ranges from $2.35 billion to $2.37 billion, slightly lower than the previous forecast of $2.37 billion to $2.39 billion.
  • In the third quarter, EPS rose to $1.52, marking an increase from $1.19 year over year (y/y).
  • Processing revenue reached $254.3 million, an 8.9% rise y/y and higher than the anticipated $249.6 million.
  • Core revenue was $180.7 million, up 8.4% y/y, slightly above the expected $180.1 million.
  • Payments revenue totaled $217.4 million, a 7.7% increase y/y, but slightly below the estimate of $219.5 million.
  • Complementary revenue grew by 12% y/y to $167.4 million, surpassing the estimate of $165.1 million.
  • The operating margin improved to 23.7% compared to 20.8% y/y.
  • Adjusted revenue was $575.4 million, a 7% increase y/y, though below the projected $580.8 million.
  • Total revenue increased by 8.6% y/y to $585.1 million.
  • Analyst recommendations for Jack Henry include 5 “buys,” 13 “holds,” and 2 “sells.”

Jack Henry & Associates on Smartkarma

On Smartkarma, independent analysts are providing insightful coverage on companies like Jack Henry & Associates. One such report from Business Breakdowns, titled “Jack Henry: VMS King – [Business Breakdowns, EP.205],” highlights Jack Henry as a fintech company offering operating system software tailored for small and mid-sized banks. The analyst expresses a bullish sentiment, noting Jack Henry’s impressive stock appreciation of 480x since their IPO in the mid-80s. Describing Jack Henry as a best-in-class operator in the vertical market software sector, the report emphasizes the company’s focus on organic growth and core product offerings.


A look at Jack Henry & Associates Smart Scores

FactorScoreMagnitude
Value2
Dividend2
Growth4
Resilience4
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Jack Henry & Associates, a company that develops and installs integrated computer systems for financial institutions, shows a promising long-term outlook based on its Smartkarma Smart Scores. With a Growth score of 4, Resilience score of 4, and Momentum score of 4, the company seems well-positioned for future success in the market. These scores indicate strong potential for growth, a solid ability to withstand challenges, and positive market momentum.

While the Value and Dividend scores are at 2, suggesting some room for improvement in terms of valuation and dividend performance, the overall outlook for Jack Henry & Associates appears optimistic. Investors may consider the company’s focus on growth, resilience, and momentum as key factors to watch for potential investment opportunities in the long term.

Summary of Jack Henry & Associates, Inc.: Jack Henry & Associates, Inc. develops, markets, and installs integrated computer systems for in-house and service bureau data processing for banks and financial institutions. The company also provides data conversion, software installation, and ongoing customer maintenance services.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Advanced Micro Devices (AMD) Earnings: Strong Beat with 1Q Adjusted EPS at 96c, Revenue Surges 36% to $7.44 Billion

By | Earnings Alerts
  • AMD reports an adjusted EPS of 96 cents, surpassing the prior year’s 62 cents and beating the estimated 94 cents.
  • Revenue grew by 36% year-over-year to $7.44 billion, exceeding the estimated $7.12 billion.
  • The adjusted gross margin remains steady at 54%, consistent with market expectations and up from 52% year-over-year.
  • Capital expenditure increased by 49% year-over-year to $212 million, above the forecasted $172.6 million.
  • Adjusted operating income rose by 57% year-over-year to $1.78 billion, matching the estimated $1.76 billion.
  • The adjusted operating margin improved to 24% from the previous year’s 21%, aligning closely with the estimated 24.6%.
  • Free cash flow grew by 92% year-over-year, reaching $727 million, though falling short of the anticipated $1.52 billion.
  • Research and development expenses increased by 13% year-over-year to $1.73 billion, slightly above the estimated $1.69 billion.
  • For the second quarter of 2025, AMD projects revenue of approximately $7.4 billion, with a variance of $300 million.
  • Shares rose by 2.9% in post-market trading, reaching $101.50, with 120,787 shares traded.
  • The company’s results and outlook underscore the robustness of its product offerings and strategic execution amid a challenging macroeconomic and regulatory environment.

Advanced Micro Devices on Smartkarma

Analyst coverage of Advanced Micro Devices on Smartkarma reveals a mix of sentiments towards the company’s performance and future prospects. Baptista Research highlights AMD’s fourth-quarter revenue growth of 24% year-over-year, driven by the data center and client segments. However, the data center segment fell short of analyst expectations, despite gaining market share in CPUs with key wins from major players like Microsoft and Google. William Keating expresses optimism for AMD’s future, noting record-high quarterly revenue and a strong revenue forecast for Q125, albeit with a share price decline due to concerns about the Data Center GPU roadmap. Nicolas Baratte emphasizes AMD’s 4Q24 performance, an upcoming GPU launch in 2025, and the CEO’s bullish outlook on Data Center AI revenue growth, indicating a buying opportunity amidst a stock correction.

On the other hand, Travis Lundy‘s analysis focuses on the MarketVectors US Semiconductor Index rebalance results, which are expected to drive significant flow expectations in December 2024, reflecting the broader industry landscape. William Keating also celebrates AMD’s CEO, Lisa Su, being named Time’s CEO of the year, recognizing her leadership in navigating challenges and driving innovation within the company. Despite facing headwinds from competitors like Arm, AMD aims to capitalize on market share gains from Intel and further develop its Instinct platform for sustained growth.


A look at Advanced Micro Devices Smart Scores

FactorScoreMagnitude
Value3
Dividend1
Growth2
Resilience4
Momentum3
OVERALL SMART SCORE2.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts using the Smartkarma Smart Scores have assessed Advanced Micro Devices‘ long-term outlook based on key factors. The outlook indicates that AMD scores well in terms of resilience, with a high score of 4. This suggests that the company has demonstrated strong stability and adaptability in the face of market challenges. Additionally, AMD receives a solid score of 3 for both value and momentum, indicating a favorable positioning in terms of its market value and upward growth potential. However, the company’s dividend score is lower at 1, suggesting that it may not be a top choice for income-focused investors. Growth prospects also receive a moderate score of 2, reflecting a mixed outlook for future expansion.

Advanced Micro Devices, Inc. (AMD) is a semiconductor company that produces a range of products including microprocessors, chipsets, and graphics solutions. While the company serves customers globally, its Smartkarma Smart Scores reveal a varied assessment of its performance across different factors. Investors considering AMD should take note of its resilience and momentum strengths, balanced against comparatively lower scores for dividend yield and growth prospects. This comprehensive evaluation can guide investment decisions regarding AMD’s long-term outlook in the ever-evolving tech industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Cirrus Logic (CRUS) Earnings Surpass Expectations with a 4Q Adjusted EPS of $1.67, Beating Estimates

By | Earnings Alerts
  • Cirrus Logic reported fourth-quarter adjusted earnings per share (EPS) of $1.67, beating both the previous year’s figure of $1.24 and the estimated $1.17.
  • The company achieved net sales of $424.5 million, a 14% increase year-over-year, surpassing the sales estimate of $380.4 million.
  • Audio net sales reached $255.3 million, marking a 13% rise compared to the previous year, outpacing the estimated $236.8 million.
  • High-performance mixed-signal product sales were $169.1 million, up 17% year-over-year, exceeding the forecasted $143.6 million.
  • The company’s adjusted gross margin improved to 53.5%, higher than the previous year’s 51.9% and matching the estimate.
  • Operating expenses stood at $140.8 million, a slight increase of 0.4% from the previous year, which was below the estimated $145.1 million.
  • Research and development (R&D) expenses remained unchanged at $103.4 million, which is lower than the forecasted $109.5 million.
  • For the first quarter, Cirrus Logic forecasts revenue between $330 million and $390 million, while the market estimate is $340.1 million.
  • Analyst ratings for the company include 5 buys, 3 holds, and no sells.

Cirrus Logic on Smartkarma

Analysts at Baptista Research on Smartkarma have been closely covering the performance of Cirrus Logic. In their report titled “Cirrus Logic: The High-Performance Mixed Signal Expansion & Other Major Drivers,” they highlighted the company’s recent financial results for the third quarter of fiscal year 2025. Cirrus Logic exceeded revenue expectations, hitting $555.7 million, driven by robust demand in the smartphone segment. Despite this positive outcome, the quarter saw a 10% decrease in sales year-over-year, primarily due to lower smartphone volumes and calendar adjustments.

In another report by Baptista Research titled “Cirrus Logic Inc.: Will Its Expansion into Laptop Markets Bring A Shift In The Competitive Dynamics? – Major Drivers,” analysts noted the strong financial performance of Cirrus Logic in the second quarter of fiscal year 2025. The company achieved record revenue of $541.9 million, nearing the upper end of their guidance range. This exceptional performance was fueled by high demand for the company’s components in the smartphone market. The report reflects a bullish sentiment towards Cirrus Logic‘s growth potential as it expands into laptop markets, potentially altering the competitive landscape.


A look at Cirrus Logic Smart Scores

FactorScoreMagnitude
Value3
Dividend1
Growth4
Resilience4
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Cirrus Logic appears to have a positive long-term outlook. With strong scores in Growth, Resilience, and Momentum, the company seems well-positioned for future success. Cirrus Logic‘s focus on developing audio and voice IC and software solutions for various applications, including mobile communications and automotive entertainment, aligns with current market trends and demands. Although the company’s Dividend score is lower, its overall performance in other key areas bodes well for its future prospects.

Cirrus Logic, Inc. stands out as a fabless semiconductor company headquartered in Austin, Texas. Specializing in audio and voice IC and software solutions, Cirrus Logic serves diverse sectors such as mobile communications, automotive entertainment, and consumer audio applications. The company’s impressive Smartkarma Smart Scores, particularly in Growth, Resilience, and Momentum, indicate its promising outlook and ability to thrive in the competitive semiconductor industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Upstart Holdings (UPST) Earnings: 1Q Revenue Surpasses Estimates with 67% Growth

By | Earnings Alerts
  • Upstart’s first-quarter revenue reached $213.4 million, marking a 67% increase year-over-year, surpassing the estimated $203.4 million.
  • Contribution profit amounted to $102.4 million, up by 26% compared to the previous year, though slightly below the expected $110.6 million.
  • Adjusted EBITDA notably improved to $42.6 million, a significant recovery from a loss of $20.3 million in the same quarter last year, and exceeded the estimate of $26.1 million.
  • The adjusted EBITDA margin increased to 20%, a substantial improvement from the previous year’s -16%, and beat the forecasted 12.7%.
  • Despite positive financial results, Upstart’s shares dropped by 6.6% in post-market trading, closing at $48.00, with 9,116 shares traded.
  • Current analyst ratings include 6 buy, 8 hold, and 3 sell recommendations.

Upstart Holdings on Smartkarma

Analysts on Smartkarma are bullish on Upstart Holdings Inc., with Baptista Research providing positive coverage of the company’s recent performance. In their report titled “Upstart Holdings Inc.: Expansion into New Loan Products & Markets As A Crucial Factor In Stock Trajectory!”, Upstart displayed strong financial results for the fourth quarter and full-year 2024, showing significant progress in operations. The company experienced a notable increase in origination volume and revenue, with a 33% sequential growth in originations and a 35% revenue increase.

Another report by Baptista Research, titled “Upstart Holdings Inc. Breaks Barriers with High-Tech Automation for Explosive Efficiency Gains! – Major Drivers”, highlighted Upstart’s use of artificial intelligence in fintech innovation. In the third quarter of 2024, Upstart achieved significant growth momentum, with a 43% sequential growth in lending volume and a return to positive adjusted EBITDA ahead of schedule. Analysts see these developments as major drivers for Upstart’s success in the market.


A look at Upstart Holdings Smart Scores

FactorScoreMagnitude
Value2
Dividend1
Growth2
Resilience2
Momentum3
OVERALL SMART SCORE2.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Upstart Holdings is a company with a mix of Smart Scores across various factors. The company scores highest in Momentum, suggesting that it may be attracting positive attention in the market. While its Value, Growth, and Resilience scores are moderate, its Dividend score is the lowest. Upstart Holdings operates as a holding company, offering a cloud-based AI lending platform to enhance credit accessibility and lower risks for its bank partners. Despite some mixed scores, the company’s strong momentum indicates potential growth opportunities in the future.

Based on the Smartkarma Smart Scores, Upstart Holdings appears to have a promising outlook with strong potential for growth indicated by its Momentum score. While Value, Growth, and Resilience scores are moderate, the company’s Dividend score is the lowest. This suggests that investors interested in long-term growth prospects may find Upstart Holdings an intriguing option to consider due to its innovative cloud-based AI lending platform aimed at improving credit access and reducing lending risks for its bank partners.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Halozyme Therapeutics (HALO) Earnings: Surpasses Estimates and Raises FY EPS Forecast

By | Earnings Alerts
  • Halozyme has raised its full-year 2025 adjusted EPS forecast to a range of $5.30 to $5.70, up from the previous $4.95 to $5.35. Analysts had estimated $4.90.
  • The company anticipates 2025 revenue to be between $1.20 billion and $1.28 billion, which is an increase from the earlier estimate of $1.15 billion to $1.23 billion.
  • First quarter results show an EPS of 93 cents and revenue of $264.9 million, surpassing the estimated $233.6 million.
  • Adjusted EPS for the first quarter is $1.11, higher than the projected 82 cents.
  • Research and development expenses came in lower than expected at $14.8 million, compared to the estimate of $21 million.
  • The company’s cash and cash equivalents stood at $176.3 million, exceeding the estimate of $109.7 million.
  • Operating income reached $141.5 million, beating the forecasted $119.9 million.
  • Halozyme is raising its 2025 financial guidance, predicting YOY growth of 18% – 26% in total revenue, 25% – 33% in adjusted EBITDA, and 25% – 35% in non-GAAP diluted EPS.
  • The company credits this growth to four recently launched products in the U.S. and Europe that are expanding coverage and reimbursement.
  • Executive comments highlight 11 growth catalysts, including new product and indication approvals as well as key reimbursement milestones.
  • Halozyme announces a $250 million share buyback amidst its upward financial momentum.
  • Analyst recommendations include 6 buys, 3 holds, and 0 sells.

Halozyme Therapeutics on Smartkarma

Analysts at Baptista Research have provided bullish coverage of Halozyme Therapeutics on Smartkarma. In their report titled “Halozyme Therapeutics: European Market Expansion to Capture The Oncology Treatment Market!”, they highlighted the company’s robust financial and operational performance in 2024. With total revenue exceeding $1 billion for the first time and a 22% increase over the previous year, Halozyme’s success was driven by a 27% growth in royalty revenue. The company’s high-margin royalty revenue was supported by the commercial success of key products like DARZALEX, Phesgo, and VYVGART Hytrulo for generalized myasthenia gravis.

In another report, “Halozyme Therapeutics Inc.: Intellectual Property Portfolio & Expansion Fueling Our β€˜Outperform’ Rating! – Major Drivers”, Baptista Research continued their bullish sentiment on Halozyme. The company’s strong financial performance in the third quarter of 2024, marked by a 34% increase in total revenues to $290 million, was attributed to a 36% rise in royalty revenues, hitting $155 million. The growth was primarily fueled by the expanded adoption of the ENHANZE drug delivery technology, particularly through products like DARZALEX subcutaneous, Phesgo, and VYVGART Hytrulo. Analysts believe that Halozyme’s intellectual property portfolio expansion is a key driver behind their ‘Outperform’ rating.


A look at Halozyme Therapeutics Smart Scores

FactorScoreMagnitude
Value2
Dividend1
Growth4
Resilience3
Momentum5
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Halozyme Therapeutics, Inc. shows a promising future according to the Smartkarma Smart Scores. With a high Growth score of 4 and Momentum score of 5, the company appears to be on a strong trajectory for advancement in the long term. These scores suggest that Halozyme Therapeutics is well-positioned for growth and has positive momentum in the market.

Although the Value score is moderate at 2 and the Dividend score is low at 1, the company’s overall outlook seems optimistic. Additionally, with a Resilience score of 3, Halozyme Therapeutics demonstrates a certain level of stability in uncertain market conditions. Overall, based on its Smartkarma Smart Scores, Halozyme Therapeutics, Inc. is a biopharmaceutical company with a focus on product development in various key markets, showcasing significant potential for growth and success in the long run.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Sarepta Therapeutics (SRPT) Earnings: 1Q Revenue Surpasses Estimates Despite Net Product Revenue Miss

By | Earnings Alerts
  • Sarepta’s first quarter revenue reached $744.9 million, surpassing the estimated $687.9 million.
  • Net product revenues fell short of expectations, totaling $611.5 million compared to an estimated $647.8 million.
  • The company reported a loss of $4.60 per share.
  • Cash and cash equivalents were significantly lower than expected at $240.9 million, against an estimate of $719.9 million.
  • Following the earnings release, Sarepta’s shares rose 2.9% in post-market trading, with the stock priced at $48.10.
  • Market activity included 20 buy recommendations, 4 hold recommendations, and no sells.

A look at Sarepta Therapeutics Smart Scores

FactorScoreMagnitude
Value2
Dividend1
Growth4
Resilience4
Momentum2
OVERALL SMART SCORE2.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Sarepta Therapeutics shows a promising long-term outlook. With high scores in Growth and Resilience, the company is well-positioned for future development and able to weather market uncertainties. Sarepta’s focus on RNA-based therapeutics for rare and infectious diseases aligns with growing healthcare needs globally, indicating potential for sustained expansion in the coming years.

Although the company’s Value and Momentum scores are more moderate, the strong emphasis on growth and resilience suggests that Sarepta Therapeutics may present compelling opportunities for investors seeking reliable long-term returns. Overall, Sarepta’s dedication to innovative treatments and global reach within the medical industry positions it as a key player in the evolving biopharmaceutical landscape.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars